Allen orcid & dryad wellcome trust v.1.0

1,579 views
1,378 views

Published on

Liz Allen presentation at ORCID -Dryad Meeting, Oxford UK, 23 May 2013 #attrib13

Published in: Technology, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,579
On SlideShare
0
From Embeds
0
Number of Embeds
26
Actions
Shares
0
Downloads
10
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide
  • ‘impact’ as generic term – talking about outputs & outcomes of our funding …Keen to find out what happens to people and things we fundAND to learn what works and what doesn’t; where are our strengths & weaknesses? committed as a funder to ensuring research outputs (inc papers & data) are made available in a way that maximises benefits to health and societywe are a leading advocate of open access & data sharing:long-standing policies with funding to support implementationwork in partnership at UK and international level to provide enabling environment active engagement in policy debates – e.g. copyright legislation reform, open data
  • Very highly cited – because we ask them to cite the data … Be good for us to be able to identify (systematically) the nature of the link …
  • Typical PapersWTCCC - data One of UK’s most renowned clinical researchers. He made his reputation by combining clinical practice with scientific and clinical studies focused on understanding the causes and consequences of obesity and insulin resistance.
  • Allen orcid & dryad wellcome trust v.1.0

    1. 1. tracking impact: a funderperspectiveLiz AllenMay 2013
    2. 2. the rationale for monitoring & evaluationo accountability & validationo management of funding initiativeso strategy & planningo policy & advocacyo learningmonitoring & evaluation are activities central to the management& improvement of an organisation or process
    3. 3. Wellcome Trust outcomeso Discoverieso Applicationso Engagemento Research leaderso Research environmento Influence
    4. 4. Monitoring progress: WT’s key indicatorsOutcomes Key indicators of progressDiscoveriesApplicationsEngagementResearch leadersResearchenvironmentInfluence1. significant advances in the generation of new knowledge2. contribute to discoveries with tangible impacts on health3. contribute to the development of enablingtechnologies, products and devices4. uptake of research into policy and practice5. enhanced level of informed debate in biomedicine6. significant engagement of key audiences & increased reach7. develop a cadre of research leaders8. evidence of significant career progression among those wesupport9. key contributions to the creation, development and maintenanceof major research resources10. contributions to the growth of centres of excellence11. significant impact on science funding & policy developments12. significant impact on global research priorities and processes
    5. 5. Wellcome Trust outcomeso Discoverieso Applicationso Engagemento Research leaderso Research environmento InfluenceWhere dowe get dataon these?
    6. 6. Key data sources for M & EWhat? Data source Data providedWT e-Val Online grant reporting tool Progress & various impacts (includingdatasets)Career Tracker Annual, panel-based cohortsurveyCareer destinationOutput Metrics Web of Science/Scopus/PubMedPaper-based citations; NormalisedCitation Impact (NCIs); other ‘indicators’F1000 ‘qualitative’ assessment of publishedworkAlt Metric/ImpactStory et al Other ‘measures’ of re-use; social mediaClinical Guidelines PubMed (via [GR] search) Papers cited on clinical guidelinesStakeholderconsultationsSurveys; interviews Survey data; narrative
    7. 7. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?
    8. 8. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?Career tracking How to stay in touch?How to find people?
    9. 9. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?Career tracking How to stay in touch?How to find people?Attribution What did the funding deliver?What did you fund?
    10. 10. Data citationCited 3139 times
    11. 11. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?Career tracking How to stay in touch?How to find people?Attribution What did the funding deliver?What did you fund?Contribution Who did what?What were the key contributions? (e.g. data curator)
    12. 12. 1991Senior ClinicalFellowship –University ofCambridge1997First description ofsingle gene defects(leptin and PC 1)leading to humanobesity1998 20021)Discovery of a formof diabetes in humansthat results frommutation in twogenes(digenic disease)2) Heinrich WielandPrize2002 2004 2006 2007 2009O’Rahilly S, Farooqi ISHuman obesity: a heritableneurobehavioral disorder thatis highly sensitive toenvironmental conditions.Diabetes 20082011 2013Coll AP, FarooqiIS, O’Rahilly S.The hormonalcontrol of foodintake. Cell.2007EUFp7fundingResearch Leaders:Stephen O’Rahilly
    13. 13. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?Career tracking How to stay in touch?How to find people?Attribution What did the funding deliver?What did you fund?Contribution Who did what?What were the key contributions? (e.g. data curator)Timeframe/lag-time Road to impact can be long & unpredictable …Impact story evolves over time …
    14. 14. 18 years between RobertEdwards first cultivating &maturing human eggs in thelab & first test tube babybeing born1978early 1960sthe long road to discoveryIn vitro fertilisation (IVF)Monoclonal antibodiesearly 1970s early 2000s30 years between Milstein &Kohler manufacturing firstmonoclonal antibodies &widespread adoption intherapies
    15. 15. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness?How to minimise reporting burdens?Career tracking How to stay in touch?How to find people?Attribution What did the funding deliver?What did you fund?Contribution Who did what?What were the key contributions? (e.g. data curator)Timeframe/lag-time Road to impact can be long & unpredictable …Impact story evolves over time …Serendipity / ripple effects Unexpected impacts & outside the field
    16. 16. Monitoring & tracking impact: challengesIssue Key challengeSelf reporting How to ensure completeness? ORCiDCareer tracking How to stay in touch? ORCiDAttribution What did the funding deliver?What did you fund?Fund Ref – standardisingfundingacknowledgements;ORCiDContribution Who did what?What were the keycontributions?Contributor rolesproject – can we movebeyond authorship?ORCiDTimeframe/lag-time Impact story evolves overtime …ORCiDSerendipity / ripple effects Unexpected impacts &outside the fieldORCiD
    17. 17. Liz AllenHead of EvaluationWellcome Trustl.allen@wellcome.ac.uk

    ×